Chris Stewart

Chris was diagnosed in 2017 with two different blood cancers – chronic lymphocytic leukemia and cutaneous follicle centre cell lymphoma. He has benefited  from novel small molecule and monoclonal antibody therapies during the course of his treatment and participated in a phase II clinical trial.  

He is active in the blood cancer community and is passionate about helping patients and caregivers be heard. He has conducted research with blood cancer patients on awareness of their disease; knowledge related to therapies; preferences related to treatment; and unmet needs. Chris has been published in a number of cancer and medical journals.  

Chris is a retired social scientist who has conducted research in more than 150 countries. During his professional career, he led basic and fundamental scientific research with a focus on programmes that were high risk/high reward in the social and behavioural sciences.